生物活性 | |||
---|---|---|---|
描述 | Briciclib targets eIF4E and inhibits the proliferation of various cancer cell lines including mantle cell leukemia, breast, gastric, and esophageal cancers with GI50 values of 9.8-12.2 nM, without affecting normal endothelial cells. It also reduces the expression of cyclin D1 and c-Myc in cancer cell lines within 8 hours[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.11mL 0.42mL 0.21mL |
10.54mL 2.11mL 1.05mL |
21.08mL 4.22mL 2.11mL |
参考文献 |
---|